Glaxosmithkline Pharmaceuticals Ltd vs Veerhealth Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2424 as of 06 May 15:30 . The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd changed from 68.1 on March 2021 to 52.5 on March 2025 . This represents a CAGR of -5.07% over 5 yearsThe P/E Ratio of Veerhealth Care Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 24401 crore on March 2021 to ₹ 48743 crore on March 2025 . This represents a CAGR of 14.84% over 5 yearsThe Market Cap of Veerhealth Care Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Glaxosmithkline Pharmaceuticals Ltd for the Dec '25 is ₹ 1091 crore as compare to the Sep '25 revenue of ₹ 1016 crore. This represent the growth of 7.4% The revenue of Veerhealth Care Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Glaxosmithkline Pharmaceuticals Ltd for the Dec '25 is ₹ 421.44 crore as compare to the Sep '25 ebitda of ₹ 371.94 crore. This represent the growth of 13.31% The ebitda of Veerhealth Care Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 182.33 crore to ₹ 295.62 crore over 7 quarters. This represents a CAGR of 31.80% The net profit of Veerhealth Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Glaxosmithkline Pharmaceuticals Ltd changed from 142.13 % on March 2021 to 99.54 % on March 2025 . This represents a CAGR of -6.88% over 5 yearsThe Dividend Payout of Veerhealth Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Glaxosmithkline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November, 1924.
The Company' s name was changed to Glaxo (India) Limited' from Glindia Limited in year 1987 and further to 'GlaxoSmithKline Pharmaceuticals Limited' from Glaxo (India) Limited effective from October 22, 2001. GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
The Company is headquartered in Mumbai and it has six branch offices, one manufacturing facility at Nashik in Maharashtra, 20 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.

About Veerhealth Care Ltd

Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance.
The main objects of the Company in 1998 got changed and accordingly the name was changed from Niyati Leasing Limited to Niyati Industries Limited and from Niyati Industries Limited to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments.
It wanted to start business in the field of infrastructure.
Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013.
Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in year 2015-16.

FAQs for the comparison of Glaxosmithkline Pharmaceuticals Ltd and Veerhealth Care Ltd

Which company has a larger market capitalization, Glaxosmithkline Pharmaceuticals Ltd or Veerhealth Care Ltd?

Market cap of Glaxosmithkline Pharmaceuticals Ltd is 41,069 Cr while Market cap of Veerhealth Care Ltd is 42 Cr

What are the key factors driving the stock performance of Glaxosmithkline Pharmaceuticals Ltd and Veerhealth Care Ltd?

The stock performance of Glaxosmithkline Pharmaceuticals Ltd and Veerhealth Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glaxosmithkline Pharmaceuticals Ltd and Veerhealth Care Ltd?

As of May 6, 2026, the Glaxosmithkline Pharmaceuticals Ltd stock price is INR ₹2424.3. On the other hand, Veerhealth Care Ltd stock price is INR ₹21.14.

How do dividend payouts of Glaxosmithkline Pharmaceuticals Ltd and Veerhealth Care Ltd compare?

To compare the dividend payouts of Glaxosmithkline Pharmaceuticals Ltd and Veerhealth Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.